Drug Approval | April 23, 2026
Cipla’s generic Ventolin HFA secures USFDA approval
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Pharma giant targets new standards of care
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
Subscribe To Our Newsletter & Stay Updated
